why choose us

First received: October 10, 2024

Clinical Trial: A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteer

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Open-Label, Single-Dose, 6-Period Crossover Study to Evaluate the Pharmacokinetics of BIIB091 Formulations and the Effect of Food in Healthy Participants

Brief Summary: In this study, researchers will learn how the body processes new tablet forms of BIIB091 when taken with and without food.One new form of BIIB091 is an "extended release" tablet, also known as "ER."This form helps release BIIB091 slowly and consistently, helping to keep steady drug levels in the body for longer.The other new form is a "gastro-retentive" tablet, also known as "GR."This form has a special coating that swells and allows BIIB091 to stay in the stomach longer.For…

Read more